Tango Therapeutics

Tango Therapeutics logo
🇺🇸United States
Ownership
Public
Established
2017-01-01
Employees
140
Market Cap
$1.2B
Website
http://www.tangotx.com
Introduction

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin, Jr....

markets.ft.com
·

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Tango Therapeutics' Adam Crystal, M.D., Ph.D., to present at Piper Sandler 36th Annual Healthcare Conference on Dec 5, 2024, at 1:30 PM ET. Live webcast available on the company's website, with a 90-day replay.
© Copyright 2024. All Rights Reserved by MedPath